À Propos de l'Entreprise
- Raison sociale: Shanghai Micro-mega Industry Co., Ltd.
- Nom international: 上海微美工业有限公司 (Shanghai Micro-mega Industry Co., Ltd.), Shanghai, China
- Marque / Nom commercial: Micro-mega
- Pays d'enregistrement: China
- Adresse: Shanghai
Founded in 2009, Shanghai Micro-mega Industry Co., Ltd. (micro-megaindustry.com) manufactures and trades pharmaceutical intermediates supporting the synthesis of major oncology and antiviral drugs. Its catalog includes intermediates for capecitabine, gefitinib, erlotinib and clofarabine, along with cytarabine (cytosine-1-beta-D-arabinofuranoside) and related deoxyribose sugar building blocks. Categorized under intermediates/fine chemicals and chiral intermediates, the company emphasizes internationally recognized approvals, experienced R&D staff, favorable delivery terms, production capacity, contract manufacturing and small-order acceptance, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.
Activités Commerciales
Produits Chimiques Pharmaceutiques
Équipements de Production & Utilités Industrielles
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
- Équipements de Production & Utilités Industrielles: Medical equipment supply
- Produits Chimiques Pharmaceutiques: 1-Chloro-3,5-di-(4-chlorobenzoyl)-2-deoxy-D-ribose, 2-Deoxy-D-ribose, Capecitabine, 5-Chlorovaleryl chloride, 5-Chlorovaleronitrile, 5-Chlorovaleric acid, Capecitabine Intermediate / CAS 161599-46-8, Gefitinib Intermediate / CAS 675126-26-8, Cytosine-1-Beta-D-Arabinofuranoside, Erlotinib Intermediate / CAS 207726-02-6, 1,2,3-tri-O-acetyl-5-deoxy-D-ribofuranose, 1-O-Acetyl-3,5-bis-(4-chlorobenzoyl)-2-deoxy-D-ribose, 1,3-Dihydroxyacetone / CAS 96-26-4, 2 '- Deoxyuridine, 2’-deoxy-2’-fluoro-2’-C-methyluridine, 2',3'-Di-O-acetyl-5'-Deoxy-5-fluorocytidine, 2,3,5-TRI-O-BENZYL-BETA-D-ARABINOFURANOSE, ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl Benzoate, 3-Amino-1,2,4-Triazole-5-carboxylic Acid Hemihydrate, 3-Nitrobenzeneacetic Acid, 3-Nitrobenzyl Bromide, 4-Chloro-N-methylpyridine-2-carboxamide, 4-[(R)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methoxy]-1-[(R)-[(, 5´-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2´,3´-diacetate, Benzenepropanoicacid, b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxy-, methyl ester,[R-(R*,S*)]-;, Capecitabine Intermediate / CAS 162204-20-8, Capecitabine Intermediate / CAS 2022-85-7, Capecitabine Intermediate / CAS 62211-93-2, Clofarabine Intermediate / CAS 15397-15-6, Clofarabine Intermediate / CAS 1839-18-5, Clofarabine Intermediate / CAS 22224-41-5, Clofarabine Intermediate / CAS 444586-86-1, Clofarabine Intermediate / CAS 6974-32-9, Clofarabine Intermediate / CAS 97614-43-2, Dapoxetine Intermediate / CAS 40856-44-8, Erlotinib Intermediate / CAS 179688-29-0, Gefitinib Intermediate / CAS 675126-27-9, Hypoxanthine, Iminostilbene /CAS 256-96-2, Piperonylic Acid
Nos Produits & Services
Évaluations
Commentaires
Aucun commentaire disponible.
Laissez votre note & commentaire